BeOne Medicines
ONC
#637
Rank
S$50.06 B
Marketcap
S$452.46
Share price
0.59%
Change (1 day)
42.36%
Change (1 year)
BeOne Medicines formerly known as BeiGene, is a multinational pharmaceutical company engaged in the R&D, commercialization of molecularly-targeted, and immuno-oncology drugs for the treatment of cancer.

EPS for BeOne Medicines (ONC)

EPS in 2025 (TTM): S$0.72

According to BeOne Medicines's latest financial reports the company's current EPS (TTM) is S$0.82. In 2024 the company made an earnings per share (EPS) of S-$7.92.

EPS history for BeOne Medicines from 2015 to 2025

Annual EPS

Year EPS Change
2025 (TTM)S$0.72-109.12%
2024S-$7.92
2022S-$24.7428.21%
2021S-$19.30-19.96%
2020S-$24.1120.81%
2019S-$19.9631.52%
2018S-$15.18417.57%
2017S-$2.93-37.16%
2016S-$4.67158.95%
2015S-$1.80

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
OPKO Health
OPK
S-$0.30-136.92%๐Ÿ‡บ๐Ÿ‡ธ USA
Onconova Therapeutics
ONTX
S-$1.21-246.15%๐Ÿ‡บ๐Ÿ‡ธ USA